CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 135 filers reported holding ENDOLOGIX INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$384,000
-52.0%
535,911
+28.0%
0.00%
-100.0%
Q3 2018$800,000
-67.1%
418,742
-2.6%
0.00%
-50.0%
Q2 2018$2,434,000
+51.1%
429,969
+13.0%
0.00%
+100.0%
Q1 2018$1,611,000
-14.0%
380,648
+8.7%
0.00%0.0%
Q4 2017$1,873,000
+24.5%
350,063
+3.8%
0.00%0.0%
Q3 2017$1,505,000
-3.6%
337,238
+5.0%
0.00%0.0%
Q2 2017$1,562,000
-25.8%
321,309
+10.5%
0.00%
-50.0%
Q1 2017$2,106,000
+33.7%
290,880
+5.7%
0.00%0.0%
Q4 2016$1,575,000
-55.6%
275,319
-0.7%
0.00%
-50.0%
Q3 2016$3,551,000
+7.7%
277,374
+4.9%
0.00%0.0%
Q2 2016$3,296,000
+59.0%
264,524
+6.7%
0.00%
+33.3%
Q1 2016$2,073,000
-0.9%
247,936
+17.4%
0.00%0.0%
Q4 2015$2,092,000
-16.9%
211,259
+3.0%
0.00%
-25.0%
Q3 2015$2,516,000
-18.4%
205,200
+2.1%
0.00%0.0%
Q2 2015$3,084,000
-3.1%
200,982
+7.8%
0.00%0.0%
Q1 2015$3,184,000
+12.4%
186,508
+0.6%
0.00%0.0%
Q4 2014$2,834,000
+57.7%
185,338
+9.4%
0.00%
+33.3%
Q3 2014$1,797,000
-28.8%
169,443
+2.2%
0.00%
-25.0%
Q2 2014$2,523,000
+17.8%
165,870
-0.3%
0.00%0.0%
Q1 2014$2,142,000
-21.3%
166,394
+6.6%
0.00%
-20.0%
Q4 2013$2,723,000
+6.9%
156,100
+0.3%
0.01%0.0%
Q3 2013$2,547,000
+32.2%
155,662
+13.2%
0.01%
+25.0%
Q2 2013$1,926,000137,5070.00%
Other shareholders
ENDOLOGIX INC shareholders Q2 2013
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,000,000$68,280,0009.00%
Essex Woodlands Management, Inc. 1,257,468$26,843,0005.32%
First Light Asset Management, LLC 277,264$4,733,0002.42%
Lisanti Capital Growth, LLC 175,060$2,988,0001.70%
ArrowMark Colorado Holdings LLC 3,150,275$53,775,0001.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,351$40,103,0001.30%
Rail-Splitter Capital Management, LLC 186,076$3,176,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,405,0000.81%
Perceptive Advisors 565,000$9,645,0000.75%
PALISADE CAPITAL MANAGEMENT, LP 1,629,329$27,813,0000.70%
View complete list of ENDOLOGIX INC shareholders